Abdurrahman Yurtaslan Ankara Oncology, education and Research Hospital

Ankara 6200

1 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Studies at this site

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling